Record Details

Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil
 
Creator Guidi, Luca
Mignini, Mariano Alejandro
 
Subject Pharmacoeconomics; Health economics
Pulmonary arterial hypertension; Tadalafil; Budget impact
 
Description This contribution is an attempt to estimate a range of Pulmonary Arterial Hypertension (PAH) prevalence in Italy using international literature and Italian drug market sales data and to evaluate the budget impact of the introduction of tadalafil among the actual drugs with specific indication for this pathology. The final epidemiological figure obtained shows a wide range of prevalence of PAH in Italy (900-3,000 cases). The introduction of tadalafil as PAH treatment should not cause a cost increase for the pharmaceutical budget considering that this new therapy will occupy essentially the patient segment actually treated with sildenafil and that it reduces, in a significant number of patients, the daily cost of PAH therapy through a stable, fixed dose, administration.
 
Publisher SEEd Medical Publishers
 
Contributor
 
Date 2010-06-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/185
10.7175/fe.v11i2.185
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 11, No 2 (2010); 77-82
2240-256X
1721-6915
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/185/171
 
Coverage


 
Rights Copyright (c) 2010 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0